Both in Pharmaceuticals
Heron Therapeutics vs Nomad Power Solutions
Over the past year HRTX returned +14.4% and NMAD returned +9.6%; their daily moves had a correlation of 0.02.
HRTX +14.4% NMAD +9.6%Growth of $1, one year, split-adjusted
| Metric | HRTX | NMAD |
|---|---|---|
| Price | $0.3610 | $3.88 |
| Market cap | $68.5M | $62.5M |
| Today | −4.12% | −5.13% |
| 1 month | +14.3% | +7.5% |
| 6 months | −63.9% | — |
| Year to date | −72.2% | — |
| 1 year | −73.3% | — |
| Revenue growth (YoY) | +1.3% | — |
| Gross margin | 69.3% | — |
| Net margin | −14.6% | — |
| P/E (TTM) | — | — |
| Price / sales | 0.5× | — |
| Net cash | -$100.0M | — |
| Dividend yield | — | — |
| Volatility (60d) | 112.4% | — |
| Short % of float | 32.1% | 10.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).